Skip to content
AnalystLens

American Water Works Company, Inc. 8-K Report, Corporate Update (Dec 8, 2022)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed December 8, 2022
Period End
December 8, 2022
Security
AWK
In the record · 2016–202610-K1110-Q328-K211

AWK filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 211 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Oct ’16Oct ’16
  2. Material agreement8-K · Nov ’19Nov ’19
  3. Leadership change8-K · Feb ’22Feb ’22
  4. Leadership change8-K · May ’26May ’26

Summary

Summary of the 8-K filed December 8, 2022. Cited figures are marked; the original filing is the authoritative source.

American Water Works Company, Inc. (AWK) announced a significant development regarding its subsidiary, Pennsylvania American Water.

The Pennsylvania Public Utility Commission (PaPUC) has approved a joint settlement in the general rate case, authorizing an annualized increase of $138 milliona in water and wastewater revenues. This approval, effective January 28, 2023, is a positive outcome for the company, as it is less than the initially requested $173 million increase but still represents a substantial revenue uplift. The increase is primarily attributed to significant capital investments, rising operating costs including chemicals, fuel, and power, and increases in pension and post-employment benefits expenses.

The settlement also allows for the recovery of deferred COVID-19 related costs. This rate increase is crucial for Pennsylvania American Water as it will support the recovery of over $1 billionb in incremental capital investments made since its last rate case.

The approved rates are expected to impact the company's financial performance positively, supporting its ongoing infrastructure improvements and operational needs. Investors should note the slight adjustment in the authorized return on equity (ROE) and capital structure ratios as approved by the PaPUC, which are generally in line with the company's previous positions, indicating regulatory stability for this key subsidiary.

Key Highlights

  1. PaPUC approves a $138 million annualized increase in water and wastewater revenues for Pennsylvania American Water, effective January 28, 2023.
  2. The approved revenue increase is lower than the initially requested $173 million but provides significant growth.
  3. The revenue increase is driven by over $1 billion in capital investments since the last rate case, increased operating costs (chemicals, fuel, power), and pension/OPEB expenses.
  4. Recovery of Pennsylvania American Water's COVID-19 deferral balance is authorized.
  5. Pennsylvania American Water's rate base now reflects inclusion of acquired water and wastewater collection and treatment system assets.
  6. Authorized return on equity (ROE) is 10.0%, with a common equity ratio of 55.20% and long-term debt ratio of 44.80%, reflecting a stable capital structure.

Frequently Asked Questions

  1. What is the primary impact of the PaPUC's decision on American Water Works Company?

    The primary impact is the approval of a $138 million annualized revenue increase for its subsidiary, Pennsylvania American Water. This will allow the company to recover significant capital investments and operating cost increases, supporting its financial health and future infrastructure development.

  2. Will the new rates be effective immediately?

    No, the new water and wastewater rates approved by the PaPUC will be effective starting January 28, 2023.

  3. What factors contributed to the approved revenue increase?

    The revenue increase is primarily driven by over $1 billion in incremental capital investments made since the last rate case, along with increased production costs (chemicals, fuel, power) and higher pension and other post-employment benefits (OPEB) expenses. Recovery of COVID-19 deferral balances is also included.

  4. How does the approved return on equity (ROE) compare to the previous rate case?

    The approved ROE is 10.0%, which is slightly higher than the previous 9.9% ROE authorized in the 2021 rate case. The common equity and long-term debt ratios remain largely consistent, indicating regulatory stability.